ST. PAUL,
Minn.–(BUSINESS WIRE)–Cardiovascular Systems,
Inc. (CSI; Nasdaq: CSII), Stealth 360°™ PAD System has been honored as a New
Technology of the Year by LifeScience Alley. The annual award is given to the
top 10 novel products that address a medical need, demonstrate the ability to
improve healthcare and have significant market potential. Expert industry
judges selected ground-breaking medical and health care technologies from
established and emerging organizations from around the U.S. and Canada. Companies presented
their technologies at New Technology Showcase of the LifeScience Alley
Conference & Expo in Minneapolis,
which drew approximately 1,500 professionals from more than 12 countries and 30
states.
“We thank LifeScience Alley for this recognition – a direct
reflection of the hard work and many contributions of our talented employees in
Minnesota,”
said David L. Martin, CSI president and chief executive officer. “This honor
recognizes CSIs innovative technology to safely treat routine and complex
peripheral arterial disease (PAD) cases. The Stealth 360° removes harmful
plaque from arteries in a very short treatment time in the hospital or
physicians office. Our technologies, combined with our growing wealth of
clinical data, are helping physicians achieve a new standard of care for PAD
patients to save limbs and lives.”
The Stealth 360° utilizes CSIs proven orbital mechanism of
action, which protects healthy tissue while removing difficult-to-treat plaque
in patients with peripheral arterial disease. The Stealth 360° eliminates the
large capital equipment portion of its predecessor product for a more compact
and easier-to-use system. With simple, convenient speed adjustments on the
handle, physicians can vary the speed of orbit and have greater control to
achieve shorter procedure times and a high percentage of plaque reduction. The
device also reduces set-up and staff time.
About LifeScience Alley
LifeScience Alley is an international leader in sharing best practices, and is
the largest state-based life sciences trade association in the United States.
With a 26-year track record of providing valuable services and results-oriented
outcomes to its members, LifeScience Alley enables business success through
educating workforces, influencing state and federal public policy, supporting
advancement in research and technological innovation, and fostering industry
connections. The Associations membership employs approximately 250,000
Minnesotans and its reach extends throughout the Midwest and Canada. For
additional information, visit: www.LifeScienceAlley.org.
About Cardiovascular Systems, Inc.
Cardiovascular Systems, Inc., based in St.
Paul, Minn., is a
medical device company focused on developing and commercializing innovative
solutions for treating vascular and coronary disease. The company’s Stealth 360°TM,
Diamondback 360® and Predator 360® PAD Systems treat calcified and fibrotic
plaque in arterial vessels throughout the leg in a few minutes of treatment
time, and address many of the limitations associated with existing surgical,
catheter and pharmacological treatment alternatives. The U.S. FDA granted
510(k) clearance for the use of the Diamondback 360° in August 2007, the
Predator 360° in March 2009 and for the Stealth 360° in March 2011. To date,
more than 55,000 PAD procedures have been performed using CSI’s PAD systems in
leading institutions across the United
States.
CSI has also commenced its ORBIT II Investigational Device
Exemption clinical trial to evaluate the safety and effectiveness of its
orbital technology in treating coronary arteries. The coronary system is
limited by federal law to investigational use and is currently not commercially
available in the United
States.
For more information, visit the companys website at www.csi360.com.
Posted by Sean Fenske, Editor-in-Chief, MDT